Changes of hemostasis variables during pregnancy

Seminars in Vascular Medicine

Volumn 3, Issue 1, 2003, Pages 13-24

  Clark, Peter ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Coagulation; Fibrinolysis; Pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR; ESTROGEN; FIBRIN; PROTEIN C; PROTEIN S; THROMBIN;

ANTICOAGULATION; CORRELATION ANALYSIS; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HEMOSTASIS; HORMONAL REGULATION; HUMAN; PATHOPHYSIOLOGY; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL PERIOD; PUERPERIUM; REVIEW; THROMBOGENESIS; VAGINAL DELIVERY; VEIN THROMBOSIS;

EID: 0041882213     PISSN: 15289648     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38329     Document Type: Review

References (76)

1. Preston F, Rosendaal F, Walker I, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-916
2. Dekker GA, De Vries JIP, Doelitzsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042-1048
3. Brenner B, Lanir N, Thaler I. HELLP syndrome associated with factor V R 506Q mutation. Br J Haematol 1996;92:999-1001
4. Clark P, Sattar N, Walker I, Greer I. The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance. Thromb Haemost 2001;85:30-35
5. Pabinger I, Kyrle PA, Heistinger M, et al. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost 1994;71:441-445
6. Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-405
7. Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984;52:176-182
8. Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79:1166-1170
9. Kjellberg U, Andersson N, Rosen S, Tengborn L, Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999;81:527-531
10. Condie R. A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by preeclampsia. Br J Obstet Gynaecol 1976;83:636-639
11. Nilsson I, Kullander S. Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gynecol Scand 1967;46:273-285
12. Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest 1981;12:141-154
13. Lefkowitz JB, Clarke AH, Barbour LA. Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol 1996;175:657-660
14. Walker MC, Garner PR, Keely EJ, Rock GA, Reis MD. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 1997;177:162-169
15. Phillips L, Rosano L, Skrodelis V. Changes in plasma factor XI (plasma thromboplastin antecedent) levels during pregnancy. Am J Obstet Gynecol 1973;116:1114-1116
16. Aznar J, Gilabert J, Estelles A, Espana F. Fibrinolytic activity and protein C in preeclampsia. Thromb Haemost 1986;55:314-317
17. Hopmeier P, Halbmayer M, Schwarz H, Heuss F, Fischer M. Protein C and protein S in mild and moderate preeclampsia. Thromb Haemost 1987;58:794-795
18. Lao TT, Yuen PM, Yin JA. Protein S and protein C levels in Chinese women during pregnancy, delivery and the puerperium. Br J Obstet Gynaecol 1989;96:167-170
19. Espana F, Gilabert J, Aznar J, et al. Complexes of activated protein C with alpha 1-antitrypsin in normal pregnancy and in severe preeclampsia. Am J Obstet Gynecol 1991;164:1310-1316
20. Woodhams BG, Candotti G, Shaw R, Kernoff PBA. Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion. Thromb Res 1989;55:99-107
21. Gatti L, Tenconi PM, Guarneri D, et al. Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Int J Clin Lab Res 1994;24:217-219
22. Faught W, Garner P, Jones G, Ivey B. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 1995;172:147-150
23. Mannucci P, Vigano S, Botasso B, et al. Protein C antigen during pregnancy, delivery and the puerperium. Thromb Haemost 1984;52:217
24. Malm J, Laurell M, Dalhback B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 1988;68:437-443
25. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994;101:488-492
26. Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and Immunologic protein S levels are decreased during pregnancy. Blood 1986;68:881-885
27. Fernandez JA, Estelles A, Gilabert J, Espana F, Aznar J. Functional and immunologic protein S in normal pregnant women and in full-term newborns. Thromb Haemost 1989;61:474-478
28. Bremme K, Ostlund E, Almqvist I, Heinonen K, Blomback M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992;80:132-137
29. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993;90:1004-1008
30. Bertina R, Koeleman B, Koster T, et al. Mutation in blood-coagulation factor-V associated with resistance to activated protein-C. Nature 1994;369:64-67
31. Cumming AM, Tait RC, Fildes S, et al. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995;90:725-727
32. Mathonet F, de Mazancourt P, Bastenaire B, et al. Activated protein C sensitivity ratio in pregnant women at delivery. Br J Haematol 1996;92:244-246
33. Nicolaes GAF, Thomassen M, Tans G, Rosing J, Hemker HC. Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals. Blood Coagul Fibrinolysis 1997;8:28-38
34. Osterud B, Robertsen R, Asvang G, Thijssen F. Resistance to activated protein C is reduced in women using oral contraceptives. Blood Coagul Fibrinolysis 1994;5:853-854
35. Mathonet F, de Mazancourt P, Denninger M-H, et al. Role of factor VIII on activated protein C resistance ratio in inflammatory diseases. Br J Haematol 1996;95:423-425
36. Lowe G, Rumley A, Woodward M, Reid E, Rumley J. Activated protein C resistance and the FV:R506Q mutation in a random population sample - associations with cardiovascular risk factors and coagulation variables. Thromb Haemost 1999;81:918-924
37. Freyburger G, Javorschi S, Labrouche S, Bernard P. Proposal for objective evaluation of the performance of various functional APC-resistance tests in genotyped patients. Thromb Haemost 1997;78:1360-1365
38. Clark P, Rosing J, Curvers J, et al. The Glasgow Outcome, APC resistance and Lipid (GOAL) pregnancy study: pregnancy-associated APC resistance. Thromb Haemost 2001;86(Suppl):278
39. Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 1987;70:343-350
40. de Boer K, ten Cate JW, Sturk A, Borm JJJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989;160:95-100
41. Reinthaller A, Mursch-Edlmayar G, Tatra G. Thrombin-antithrombin III complex levels in normal pregnancy, with hypertensive disorders and after delivery. Br J Obstet Gynaecol 1990;97:506-510
42. Cadroy Y, Grandjean H, Pichon J, et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993;100:416-20
43. Comeglio P, Fedi S, Liotta AA, et al. Blood clotting activation during normal pregnancy. Thromb Res 1996;84:199-202
44. Delorme M, Burrows R, Orfosu F, Andrew M. Thrombin regulation in mother and fetus during pregnancy. Semin Thromb Hemost 1992;18:81-90
45. Weenink GH,Treffers PE, Kahle LH, ten Cate JW. Antithrombin III in normal pregnancy. Thromb Res 1982;26:281-287
46. Ramalakshmi BA, Raju LA, Raman L. Antithrombin III levels in pregnancy induced hypertension. Nat Med J India 1995;8:61-62
47. Maruyama I, Bell C, Majerus P. Thrombomodulin is found on endothelium of arteries, veins, capillaries and lymphatics and on syncytiotrophoblast of human placenta. J Cell Biol 1985;101:363-371
48. Esmon C, Owen W. Identification of an endothelial cell co-factor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci U S A 1981;78:2249-2252
49. Esmon C, Esmon N, Harris K. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalysed fibrin formation and factor V activation. J Biol Chem 1982;257:7944-7947
50. Esmon N, Carroll R, Esmon C. Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 1983;258:12238-12242
51. Hofsteenge J, Taguchi H, Stone S. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrate and inhibitors. Biochem J 1986;237:243-251
52. Ishii H, Majerus P. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985;76:2178-2181
53. Boffa M-C. Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker. Haemostasis 1996;26:233-243
54. Boffa M-C, Valsecchi L, Fausto A, et al. Predictive value of plasma thrombomodulin in pre-eclampsia and gestational hypertension. Thromb Haemost 1998;79:1092-1095
55. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterisation. J Biol Chem 1983;258:163-168
56. Heeb MJ, Espana F, Griffin JH. Inhibition and complexation of activated protein C by two major inhibitors in plasma. Blood 1989;73:446-454
57. Marlar RA, Kressin DC, Madden RM. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma. Thromb Haemost 1993;69:16-20
58. Hoogendoorn H, Toh CH, Nesheim ME, Giles AR. Alpha 2-macroglobulin binds and inhibits activated protein C. Blood 1991;78:2283-2290
59. Gruber A, Griffin J. Direct detection of activated protein C in blood from human subjects. Blood 1992;79:2340-2348
60. Bauer KA, Kass BL, Beeler DL, Rosenberg RD. Detection of protein C activation in humans. J Clin Invest 1984;74:2033-2041
61. Gerbasi F, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 1990;75:385-389
62. Condie RG, Ogston D. Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol 1976;83:938-942
63. Caron C, Goudemand J, Marey A, et al. Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension? Thromb Haemost 1991;66:410-414
64. Sattar N, Greet I, Rumley A, et al. A longitudinal study of the relationship between haemostatic, lipid and oestradiol changes during normal human pregnancy. Thromb Haemost 1999;81:71-75
65. Wright J, Cooper P, Astedt B, et al. Fibrinolysis during normal human pregnancy: complex inter -relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time. Br J Haematol 1988;69:253-258
66. Ballegeer V, Mombaerts P, Declerck P, et al. Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy. Thromb Haemost 1987;58:1030-1032
67. Mercelina-Roumans PE, Ubachs JM, van Wersch JW. Coagulation and fibrinolysis in smoking and nonsmoking pregnant women. Br J Obstet Gynaecol 1996;103:789-794
68. Schlit AF, Col-De-Beys C, Moriau M, Lavenne-Pardonge E. Acquired activated protein C resistance in pregnancy. Thromb Res 1996;84:203-206
69. Bonnar J, Prentice C, McNicol G, Douglas A. Haemostatic mechanism in the uterine circulation during placental separation. Br Med J 1970;2:564-567
70. Gilabert J, Aznar J, Parrilla J, et al. Alteration in the coagulation and fibrinolysis systems in pregnancy, labour and puerperium, with special reference to a possible transitory state of intravascular coagulation during labour. Thromb Haemost 1978;40:387-396
71. Henrikson K. Thrombin as a hormonally regulated growth factor in oestrogen-responsive tissue. Semin Thromb Hemost 1992;18:53-59
72. Jazin EE, Dickerman HW, Henrikson KP. Estrogen regulation of a tissue factor-like procoagulant in the immature rat uterus. Endocrinology 1990;126:176-185
73. Bonnar J, Sheppard BL. The vascular supply of the placenta in normal and abnormal pregnancy. In: Baustein A, ed. Pathology of the Female Genital Tract. New York: Springer Verlag; 1977:673-689
74. McColl MD, Ramsay JE, Tait RC, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997;78:1183-1188
75. Bokarewa MI, Wramsby M, Bremme K, Blomback M. Variability of the response to activated protein C during normal pregnancy. Blood Coagul Fibrinolysis 1997;8:239-244
76. Warwick R, Hutton RA, Goff L, Letsky E, Heard M. Changes in protein C and free protein S during pregnancy and following hysterectomy. J R Soc Med 1989;82:591-594